Back to results
UnknownPhase 2

Efficacy and Safety Study of DCB-AD1 in Patients With Mild to Moderate Alzheimer's Disease

NCT00154635

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

NTUH

Taipei, Taipei, Taiwan

+1 additional location

Contact

Ming-Jang Chiu, MD, PhD

886-968661507mjchiu@ntumc.org
View on ClinicalTrials.gov
Efficacy and Safety Study of DCB-AD1 in Patients With Mild to Moderate Alzheimer's Disease — TrialFind